HCV Genotype Distribution and Clinical Characteristics of HCV Mono-Infected and HCV/HIV Co-Infected Patients in Liangshan Prefecture, Sichuan Province, China

被引:1
|
作者
Cao, Bianchuan [1 ]
Liu, Mei [2 ]
Jiang, Tao [2 ]
Yu, Qinghua [2 ]
Yuan, Tianru [2 ]
Ding, Ping [2 ]
Zhou, Xian [2 ]
Huang, Yongmao [1 ]
Zou, Yongsheng [1 ]
Huang, Fuli [1 ,3 ]
机构
[1] Southwest Med Univ, Affiliated Hosp, Luzhou, Peoples R China
[2] First Peoples Hosp Yuexi Cty, Antiviral Therapy Ctr, Liangshan, Peoples R China
[3] Southwest Med Univ, Affiliated Hosp, Dept Infect Dis, 25 Taiping St, Luzhou 646000, Sichuan, Peoples R China
关键词
hepatitis c; HIV; genotype distribution; clinical characteristics; INJECTION-DRUG USERS; VIRUS-INFECTION; DIAGNOSIS;
D O I
10.1177/23259582231217810
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: The present study aimed to characterize the genotype distribution and clinical characteristics of HCV monoinfected and HCV/HIV coinfected patients in the Liangshan Prefecture, Sichuan Province, China. Methods: All the patients were divided into HCV monoinfection and HCV/HIV coinfection groups according to whether they were complicated with HIV infection. The data from the two groups were collected. Results: In this study, HCV genotype 3 was the most common genotype in both groups, while HCV genotype 6 was significantly higher in the coinfection group than in the monoinfection group (p = 0.046). The white blood cell count, total bilirubin level, and HCV RNA were significantly higher in the HCV monoinfection group than that in the HCV/HIV coinfection group (p = 0.031; p < 0.001; p = 0.027, respectively). Conclusion: HCV prevalence was high in HIV-positive patients in the Liangshan Prefecture. Thus, incorporating screening and management of HCV monoinfection and HCV/HIV coinfection is needed in local region programs.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] HCV treatment in HIV/HCV co-infected patients A single center, observational study
    Androutsakos, T.
    Sipsas, N.
    Kontos, A.
    Hatzis, G.
    ARCHIVES OF HELLENIC MEDICINE, 2019, 36 (06): : 787 - 791
  • [22] Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients
    Giovanni Mazzola
    Lucia Adamoli
    Vincenza Calvaruso
    Fabio Salvatore Macaluso
    Pietro Colletti
    Sergio Mazzola
    Adriana Cervo
    Marcello Trizzino
    Francesco Di Lorenzo
    Chiara Iaria
    Tullio Prestileo
    Ambrogio Orlando
    Vito Di Marco
    Antonio Cascio
    Infection, 2019, 47 : 409 - 415
  • [23] Short- and Long-Term Immunological Responses in Chronic HCV/HIV Co-Infected Compared to HCV Mono-Infected Patients after DAA Therapy
    Farcomeni, Stefania
    Moretti, Sonia
    Fimiani, Caterina
    Sulekova, Lucia Fontanelli
    Vescio, Fenicia
    Sernicola, Leonardo
    Maggiorella, Maria T.
    Remoli, Anna Lisa
    Picconi, Orietta
    Mosca, Luciana
    Esvan, Rozenn
    Biliotti, Elisa
    Ciccozzi, Massimo
    Sgarbanti, Marco
    Taliani, Gloria
    Borsetti, Alessandra
    PATHOGENS, 2021, 10 (11):
  • [24] HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
    Garbuglia, Anna Rosa
    Monachetti, Alessia
    Galli, Claudio
    Sabatini, Rosella
    Ferreri, Monica Lucia
    Capobianchi, Maria Rosaria
    Bagnarelli, Patrizia
    BMC INFECTIOUS DISEASES, 2014, 14
  • [25] The GNB3 C825T polymorphism affects response to HCV therapy with pegy1ated interferon in HCV/HIV co-infected but not in HCV mono-infected patients
    Ahlenstiel, Golo
    Nischalke, Hans Dieter
    Bueren, Karin
    Berg, Thomas
    Vogel, Martin
    Biermer, Michael
    Gruenhage, Frank
    Sauerbruch, Tilman
    Rockstroh, Juergen
    Spengler, Ulrich
    Nattermann, Jacob
    JOURNAL OF HEPATOLOGY, 2007, 47 (03) : 348 - 355
  • [26] Efficacy of Sovodak in the Management of Patients Co-infected with HIV/HCV
    Somi, Mohammad Hossein
    Sepehri, Bita
    Nikniaz, Zeinab
    Sedghi, Roya
    ADVANCED PHARMACEUTICAL BULLETIN, 2020, 10 (04) : 662 - 665
  • [27] Hospital epidemiology of patients co-infected by HIV and HCV
    Thélot, B
    Pialoux, G
    Delhommeau, A
    Piroth, L
    Salmon-Céron, D
    MEDECINE ET MALADIES INFECTIEUSES, 2001, 31 (10): : 605 - 608
  • [28] Current characteristics of hemophilia patients co-infected with HIV/HCV in Japan
    Miuma, Satoshi
    Hidaka, Masaaki
    Takatsuki, Mitsuhisa
    Natsuda, Koji
    Soyama, Akihiko
    Miyaaki, Hisamitsu
    Kanda, Yasuko
    Tamada, Yoko
    Shibata, Hidetaka
    Ozawa, Eisuke
    Taura, Naota
    Eguchi, Susumu
    Nakao, Kazuhiko
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (02) : 2148 - 2155
  • [29] Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial
    Mary-Anne Doyle
    Joel Singer
    Terry Lee
    Miriam Muir
    Curtis Cooper
    Trials, 17
  • [30] High HCV treatment uptake in the Swedish HIV/HCV co-infected cohort
    Stenkvist, Jenny
    Weiland, Ola
    Sonnerborg, Anders
    Blaxhult, Anders
    Falconer, Karolin
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2014, 46 (09) : 624 - 632